{"description":"AE Description: Any sign or symptom that occurs during the post-infusion period (starting at the day of first infusion of CTL019 until the end of the study).","eventGroups":[{"deathsNumAffected":22,"deathsNumAtRisk":97,"description":"All participants who were enrolled in the study","id":"EG000","otherNumAffected":95,"otherNumAtRisk":97,"seriousNumAffected":52,"seriousNumAtRisk":97,"title":"CTL019"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":26,"numAtRisk":97}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":97}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":97}],"term":"Leukopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":97}],"term":"Lymphopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":43,"numAtRisk":97}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":97}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":97}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":97}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":24,"numAtRisk":97}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":97}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":97}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":97}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":97}],"term":"Chills"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":97}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":97}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":30,"numAtRisk":97}],"term":"Cytokine release syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":97}],"term":"Hypogammaglobulinaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":97}],"term":"Bronchitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":97}],"term":"COVID-19"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":97}],"term":"Nasopharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":97}],"term":"Respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":97}],"term":"Sinusitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":97}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":97}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":97}],"term":"Lymphocyte count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":97}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":97}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":97}],"term":"SARS-CoV-2 test negative"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":97}],"term":"Weight decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":22,"numAtRisk":97}],"term":"White blood cell count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":97}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":97}],"term":"Hyperglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":97}],"term":"Hyperkalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":97}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":97}],"term":"Hypomagnesaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":97}],"term":"Hypophosphataemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":97}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":97}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":97}],"term":"Muscle spasms"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":97}],"term":"Myalgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":97}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":97}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":23,"numAtRisk":97}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":97}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":97}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":97}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":97}],"term":"Oropharyngeal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":97}],"term":"Pleural effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":97}],"term":"Productive cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":97}],"term":"Dry skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":97}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":97}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":97}],"term":"Hypotension"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":97}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":97}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Cardiac arrest"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Ventricular fibrillation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Blindness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Gastrointestinal haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Gastrointestinal ulcer"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Glossitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Small intestinal obstruction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Stomatitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Catheter site haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":97}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":19,"numAtRisk":97}],"term":"Cytokine release syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Graft versus host disease in gastrointestinal tract"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":97}],"term":"COVID-19"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"COVID-19 pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Coronavirus pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Diverticulitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Encephalitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Human herpesvirus 6 encephalitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Localised infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Lower respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Parainfluenzae virus infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Perirectal abscess"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":97}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Pneumonia haemophilus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Pneumonia respiratory syncytial viral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Progressive multifocal leukoencephalopathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Pseudomonal bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Rhinovirus infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":97}],"term":"Sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Sinusitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Skin infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Tonsillitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Varicella zoster virus infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":97}],"term":"Infusion related reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Failure to thrive"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Muscle spasms"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Acute myeloid leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":97}],"term":"Basal cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Bladder transitional cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Bowen's disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Malignant melanoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Metastatic squamous cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":97}],"term":"Myelodysplastic syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":97}],"term":"Squamous cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":97}],"term":"Encephalopathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Immune effector cell-associated neurotoxicity syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Ruptured cerebral aneurysm"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Syncope"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Acute kidney injury"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":97}],"term":"Acute respiratory failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":97}],"term":"Pleural effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Pneumothorax"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (28.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":97}],"term":"Pulmonary embolism"}],"timeFrame":"Adverse events were collected during the post-infusion period (starting at the day of infusion until the end of the study), up to maximum duration of 60 months for each patient. All-cause mortality was assessed from day of infusion up to 65.8 months."}